Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 2/20 | 0.50 |
| ▸ | CYCS | P99999 | 3/20 | 0.49 |
| ▸ | TERT | O14746 | 3/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.47 |
| ▸ | STAT1 | P42224 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL249199 | 1.00 | TOP1 (0.50) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL31296593 | 1.00 | TOP1 (0.50) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL29648445 | 0.98 | TERT (0.51) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL8865323 | 0.98 | TERT (0.51) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL30297908 | 0.98 | TERT (0.51) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL1640992 | 0.95 | TOP1 (0.54) | TOP1CYCSTERTENPP2STAT3 | |
| Temoporfin SCHEMBL6422 | 0.90 | TOP1 (0.43) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL5100886 | 0.90 | TOP1 (0.43) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL17651778 | 0.90 | TOP1 (0.43) | TOP1CYCSTERTENPP2STAT3 | |
| SCHEMBL17651811 | 0.90 | TOP1 (0.43) | TOP1CYCSTERTENPP2STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119454945-A | Ultrasonic activated carrier-free nano-drug and preparation method and application thereof | 浙江大学 | 2025-02-18 | — | — | CN | claimed |
| CN-112940268-B | Interface in-situ growth metal-organic framework material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-04-12 | — | — | CN | claimed |
| CN-119454945-A | Ultrasonic activated carrier-free nano-drug and preparation method and application thereof | 浙江大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-118852183-A | Pharmaceutical compound with protein crown regulation function and application thereof | 中国科学技术大学 | 2024-10-29 | — | — | CN | disclosed |
| US-20240325334-A1 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-10-03 | — | — | US | disclosed |
| CN-117396611-A | Method for delivering a cargo into a cell | 成思有限责任公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-113474383-B | Free radical polymerizable composition | 波林复合材料美国股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023038386-A1 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | 서울대학교산학협력단 | 2023-03-16 | — | — | WO | disclosed |
| CN-112940268-B | Interface in-situ growth metal-organic framework material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-04-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240325334-A1 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | NOS1, NOS2, NOS3 | TOP1 293/4885CYCS 113/4885TERT 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.